Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparison of four strong opioid strategies for cancer pain
2010-021017-23Phase 4Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Nov 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of morphine, oxycodone, fentanyl and buprenorphine in cancer pain (4 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Proportion of non-responders. Started Nov 2010; status: completed.
02
Drugs
morphineoxycodonefentanylbuprenorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2010-021017-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021017-23.